 |
Prospector
Profile
07.1233
|
| |
| Verenium Corporation |
NAICS |
325193 |
| 55 Cambridge Parkway
Cambridge, CA 02142 |
Description |
Ethanol Mfg. |
| (617) 674-5300 |
Employees |
287 |
| http://www.verenium.com/ |
Revenue |
(mil) |
49.1980 |
| |
Income |
(mil) |
-39.2700 |
| |
Assets |
(mil) |
79.9050 |
| |
Liability |
(mil) |
36.9800 |
| |
(for the year ended 2006-12-31) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
Verenium Corporation reported a net loss of $55,200,000 on revenues of $11,134,000 for the three months ended June 30, 2007, compared to a net loss of $7,772,000 on revenues of $10,598,000 during the same quarter last year. For the six months ended June 30, 2007, the Company reported a net loss of $65,518,000, more than double the net loss of $29,173,000 reported during the first half of last year. The Company has an accumulated deficit of $395,004,000 in its June 30, 2007 balance sheet.
|
| |
|
Intellectual Property:
The Company's intellectual property consists of patents, copyrights, trade secrets, know-how, and trademarks. As of December 31, 2006, the Company owned 242 issued patents relating to its technologies and had over 500 patents pending. In addition, as of December 31, 2006, the Company had in-licensed over 100 patents or patent applications that strengthen its patent position. It also relies on trade secrets, technical know-how, and continuing invention to develop and maintain competitive position. [SEC Filing S-4 03-19-07]
|
| |
|
Description:
The Company engages primarily in the development and commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel.
|
| |
|
Officers:
James H. Cavanaugh, Ph.D. (Chair); Carlos A. Riva (Pres., CEO & Dir.); John A. McCarthy, Jr. (EVP & CFO); John R. Malloy, Jr. (EVP); Michael H. Baum (EVP); Peter Johnson (Dir.); Mark Leschly (Dir.); Joshue Ruch (Dir.); Melvin I. Simon, Ph.D. (Dir.); Cheryl Wenzinger (Dir.); Michael Zak (Dir.)
|
| |
|
Auditor:
Ernst & Young LLP
|
| |
|
Securities:
Common Stock-Symbol VRNM; NasdaqGM;
62,709,240 common shares outstanding as of July 31, 2007.
|
| |
| |
| |
| return to main page |
|
|
